India's drug watchdog, CDSCO, is under scrutiny for a 74-day delay in issuing a public alert about a counterfeit anti-rabies vaccine in 2025, despite being notified by the manufacturer. This lapse endangered thousands of dog-bite victims and highlights broader issues of regulatory opacity and enforcement.
Read the full story on Quick Digest